Summary Case 5: Prolonged Thrombin time in a patient with multiple myeloma;Fall 5: Verlängerte Thrombinzeit bei einem Patienten mit multiplem Myelom

Therapeutische Umschau

Volumn 56, Issue 9, 1999, Pages 491-494

  Bohler, André ^a   Redondo, M ^a   Lammle B ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; IMMUNOGLOBULIN KAPPA CHAIN;

ARTICLE; BLEEDING DISORDER; BLOOD; CASE REPORT; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIPLE MYELOMA; THROMBIN TIME;

DIAGNOSIS, DIFFERENTIAL; FIBRIN; HEMORRHAGIC DISORDERS; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; THROMBIN TIME;

EID: 0033191508     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.56.9.491     Document Type: Article

References (4)

1. Barth A, Furlan M, Lämmle B. Unerwartet verlängerte Thrombinzeit. Schweiz Med Wochenschr 1993;123:523.
2. Bänninger H, Hardegger Th, Tobler A, Barth A, Schüpbach P, Reinhart W, Lämmle B, Furlan M. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V.Br J Haematol 1993;85:528.
3. Colwell NS, Tollefsen DM, Blinder MA. Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder. Br J Haematol 1997;97:219.
4. Tefferi A, Nichols WL, Bowie EJW. Circulating heparin-like anticoagulants: report of five consecutive cases and a review. Am J Med 1990;88:184.